Dissolving the burden of generalized anxiety disorderNINAN, Philip T.The Journal of clinical psychiatry. Supplement. 2001, Vol 62, Num 19, pp 5-10Article

Neurobiology and etiology of panic disorderNINAN, Philip T; DUNLOP, Boadie W.The Journal of clinical psychiatry. Supplement. 2005, Vol 66, Num 4, pp 3-7, 5 p.Conference Paper

Retrospective Analysis of Suicidality in Patients Treated With the Antidepressant DesvenlafaxineTOURIAN, Karen A; PADMANABHAN, Krishna; GROARK, Jim et al.Journal of clinical psychopharmacology. 2010, Vol 30, Num 4, pp 411-416, issn 0271-0749, 6 p.Article

A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depressionGEORGE, Mark S; RUSH, A. John; DUNNER, David et al.Biological psychiatry (1969). 2005, Vol 58, Num 5, pp 364-373, issn 0006-3223, 10 p.Article

Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: Results from the PREVENT studyTHASE, Michael E; GELENBERG, Alan; KORNSTEIN, Susan G et al.Journal of psychiatric research. 2011, Vol 45, Num 3, pp 412-420, issn 0022-3956, 9 p.Article

Effects of 12 months of vagus nerve stimulation in treatment-resistant depression : A naturalistic studyRUSH, A. John; SACKEIM, Harold A; CARPENTER, Linda et al.Biological psychiatry (1969). 2005, Vol 58, Num 5, pp 355-363, issn 0006-3223, 9 p.Article

Correlation between patient and clinician assessments of depression severity in the PREVENT studyDUNLOP, Boadie W; LI, Thomas; KORNSTEIN, Susan G et al.Psychiatry research (Print). 2010, Vol 177, Num 1-2, pp 177-183, issn 0165-1781, 7 p.Article

Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorderDUNLOP, Boadie W; LI, Thomas; KORNSTEIN, Susan G et al.Journal of psychiatric research. 2011, Vol 45, Num 1, pp 96-103, issn 0022-3956, 8 p.Article

Insight and treatment outcome in Obsessive-Compulsive disorderEISEN, Jane L; RASMUSSEN, Steven A; PHILLIPS, Katharine A et al.Comprehensive psychiatry. 2001, Vol 42, Num 6, pp 494-497, issn 0010-440XArticle

Recovery and subsequent recurrence in patients with recurrent major depressive disorderDUNLOP, Boadie W; HOLLAND, Peter; BAO, Weihang et al.Journal of psychiatric research. 2012, Vol 46, Num 6, pp 708-715, issn 0022-3956, 8 p.Article

BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxineNINAN, Philip T; SHELTON, Richard C; WEIHANG BAO et al.Progress in neuro-psychopharmacology & biological psychiatry. 2014, Vol 48, pp 86-91, issn 0278-5846, 6 p.Article

The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorderGARLOW, Steven J; DUNLOP, Boadie W; NINAN, Philip T et al.Journal of psychiatric research. 2012, Vol 46, Num 11, pp 1406-1413, issn 0022-3956, 8 p.Article

Adjunctive Modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigueNINAN, Philip T; HASSMAN, Howard A; GLASS, Steven J et al.The Journal of clinical psychiatry. 2004, Vol 65, Num 3, pp 414-420, issn 0160-6689, 7 p.Article

Efficacy and Safety of Desvenlafaxine 50 mg/d in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive DisorderCLAYTON, Anita H; KORNSTEIN, Susan G; DUNLOP, Boadie W et al.The Journal of clinical psychiatry. 2013, Vol 74, Num 10, pp 1010-1017, issn 0160-6689, 8 p.Article

Sexual Functioning in Patients With Recurrent Major Depressive Disorder Enrolled in the PREVENT StudyGELENBERG, Alan J; DUNNER, David L; ROTHSCHILD, Anthony J et al.The Journal of nervous and mental disease. 2013, Vol 201, Num 4, pp 266-273, issn 0022-3018, 8 p.Article

A Meta-analysis of Factors Impacting Detection of Antidepressant Efficacy in Clinical Trials: The Importance of Academic SitesDUNLOP, Boadie W; THASE, Michael E; WUN, Chuan-Chuan et al.Neuropsychopharmacology (New York, NY). 2012, Vol 37, Num 13, pp 2830-2836, issn 0893-133X, 7 p.Article

Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?CAPURON, Lucile; FORNWALT, Fiona B; KNIGHT, Bettina T et al.Journal of affective disorders. 2009, Vol 119, Num 1-3, pp 181-185, issn 0165-0327, 5 p.Article

Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression : a secondary analysis of data from the PREVENT studyKORNSTEIN, Susan G; KOCSIS, James H; KELLER, Martin et al.International clinical psychopharmacology. 2008, Vol 23, Num 6, pp 357-363, issn 0268-1315, 7 p.Article

A double-blind, placebo-controlled study of the efficacy and safety of controlled-release Fluvoxamine in patients with obsessive-compulsive disorderHOLLANDER, Eric; KORAN, Lorrin M; GOODMAN, Wayne K et al.The Journal of clinical psychiatry. 2003, Vol 64, Num 6, pp 640-647, issn 0160-6689, 8 p.Article

Symptomatic and syndromal anxiety in chronic forms of major depression: Effect of nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and their combinationNINAN, Philip T; RUSH, A. John; KELLER, Martin B et al.The Journal of clinical psychiatry. 2002, Vol 63, Num 5, pp 434-441, issn 0160-6689Article

A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depressionKEITNER, Gabor I; GARLOW, Steven J; RYAN, Christine E et al.Journal of psychiatric research. 2009, Vol 43, Num 3, pp 205-214, issn 0022-3956, 10 p.Article

High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder : A multicenter double-blind trialNINAN, Philip T; KORAN, Lorrin M; KIEV, Ari et al.The Journal of clinical psychiatry. 2006, Vol 67, Num 1, pp 15-22, issn 0160-6689, 8 p.Article

Cytochrome P450 2D6 Phenotype Predicts Antidepressant Efficacy of Venlafaxine: A Secondary Analysis of 4 Studies in Major Depressive DisorderLOBELLO, Kasia W; PRESKORN, Sheldon H; GUICO-PABIA, Christine J et al.The Journal of clinical psychiatry. 2010, Vol 71, Num 11, pp 1482-1487, issn 0160-6689, 6 p.Article

Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness : A double-blind, placebo-controlled studyDUNLOP, Boadie W; CRITS-CHRISTOPH, Paul; EVANS, Dwight L et al.Journal of clinical psychopharmacology. 2007, Vol 27, Num 6, pp 614-619, issn 0271-0749, 6 p.Article

Differential effects of nefazodone and Cognitive Behavioral Analysis System of psychotherapy on insomnia associated with chronic forms of major depressionTHASE, Michael E; RUSH, A. John; BORIAN, Frances E et al.The Journal of clinical psychiatry. 2002, Vol 63, Num 6, pp 493-500, issn 0160-6689Article